Integra LifeSciences (IART) Tops Q3 Views by 1c; Guides FY09
More News related to IART
- Integra LifeSciences Donates Over $300,000 Worth of Medical Instruments to Haiti Earthquake Relief Efforts
- Integra LifeSciences to Present at the Deutsche Bank 2010 Small and Mid Cap Conference
- Barrington Research Initiates Coverage on Integra LifeSciences (IART) with an Outperform; Growth Opportunites in End Markets
- Integra LifeSciences Announces First Two-Level Surgery With Paramount(R) Pedicle Screw System for Minimally Invasive Spine Surgery
- Integra LifeSciences (IART) First Clinical for Coral Spinal System Performed
More News related to Earnings
- HNI Corporation (HNI) Tops Q1 EPS by 2c; Revs Light
- Team Health (TMH) Reports Mixed Q4 Results
- Baidu (BIDU) Blows the Lid Off Q4, Shares Jump
- Aspen Insurance (AHL) Posts Q4 adj.-EPS of $1.44, Tops Views
- Acadia Realty Trust (AKR) Misses Q4 FFO by 1c; Guides Below for FY10
Integra LifeSciences Corporation (NASDAQ: IART) reports Q3 EPS of $0.53, 1 cent better than the analyst estimate of $0.52. Revenue for the quarter was $172.30 million, which compares to the estimate of $170.50 million.
Reiterates FY09 revs of $680 - $700 million, and sees adjusted EPS of $2.00 - $2.20. The consensus is $681.61 million and $2.11, respectively.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.63Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
